intz20160831

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): Yes ☐ No ☒

The number of shares outstanding of the Registrant’s Common Stock, $0.01 par value, on November 1, 2016 was 12,747,836.

	September 30, 2016			December 31, 2015
ASSETS
Current Assets:
Cash and cash equivalents	$	210		$	102
Accounts receivable		588			580
Inventories		52			45
Prepaid expenses		41			69
Total current assets		891			796
Property and equipment, net		314			486
Other assets		41			43
TOTAL ASSETS	$	1,246		$	1,325

LIABILITIES AND STOCKHOLDERS’ DEFICIT

Current Liabilities:
Accounts payable and accrued expenses	$	876		$	840
Dividends payable		267			160
Obligations under capital lease, current portion		142			197
Deferred revenue		622			386
Total current liabilities		1,907			1,583

Loan payable to officer		2,335			1,530
Obligations under capital lease, noncurrent portion		51			139

Commitments and contingencies
Stockholders’ deficit:
Preferred stock, $0.01 par value: Authorized shares – 5,000
Series 1 shares issued and outstanding — 200 Liquidation preference of $1,100 in 2016 and $1,063 in 2015		707			707
Series 2 shares issued and outstanding — 460 Liquidation preference of $1,256 in 2016 and $1,212 in 2015		724			724
Series 3 shares issued and outstanding — 289 Liquidation preference of $689 in 2016 and $665 in 2015		412			412
Common stock, $0.01 par value:
Authorized shares — 80,000
Issued shares — 12,758 in 2016 and 12,622 in 2015 Outstanding shares — 12,748 in 2016 and 12,612 in 2015		128			126
Common stock held in treasury, at cost – 10 shares		(362	)		(362	)
Additional paid-in capital		56,609			56,520
Accumulated deficit		(61,158	)		(59,947	)
Accumulated other comprehensive loss		(107	)		(107	)
Total stockholders’ deficit		(3,047	)		(1,927	)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT	$	1,246		$	1,325

INTRUSION INC. AND SUBSIDIARIES
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share amounts)

	Three Months Ended						Nine Months Ended
	September 30, 2016			September 30, 2015			September 30, 2016			September 30, 2015
Net product revenue	$	1,595		$	1,544		$	4,693		$	5,309
Net customer support and maintenance revenue		—			8			—			27
Total revenue		1,595			1,552			4,693			5,336
Cost of product revenue		610			567			1,677			1,975
Cost of customer support and maintenance revenue		—			3			—			9
Total cost of revenue		610			570			1,677			1,984

Gross profit		985			982			3,016			3,352

Operating expenses:
Sales and marketing		429			490			1,276			1,432
Research and development		508			592			1,908			1,641
General and administrative		292			305			941			946

Operating loss		(244	)		(405	)		(1,109	)		(667	)

Interest expense, net		(36	)		(27	)		(102	)		(79	)

Net loss	$	(280	)	$	(432	)	$	(1,211	)	$	(746	)

Preferred stock dividends accrued		(35	)		(35	)		(104	)		(104	)
Net loss attributable to common stockholders	$	(315	)	$	(467	)	$	(1,315	)	$	(850	)

Net loss per share attributable to common stockholders: Basic	$	(0.02	)	$	(0.04	)	$	(0.10	)	$	(0.07	)
Diluted	$	(0.02	)	$	(0.04	)	$	(0.10	)	$	(0.07	)

Weighted average common shares outstanding:
Basic		12,748			12,612			12,733			12,593
Diluted		12,748			12,612			12,733			12,593

INTRUSION INC. AND SUBSIDIARIES
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)

	Nine Months Ended
	September 30, 2016			September 30, 2015
Operating Activities:
Net loss	$	(1,211	)	$	(746	)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization		218			231
Stock-based compensation		82			161
Penalties and waived penalties on dividends		13			3
Changes in operating assets and liabilities:
Accounts receivable		(8	)		117
Inventories		(7	)		—
Prepaid expenses and other assets		30			89
Accounts payable and accrued expenses		41			85
Deferred revenue		236			342
Net cash provided by (used in) operating activities		(606	)		282

Investing Activities:
Purchases of property and equipment		(41	)		(112	)

Financing Activities:
Proceeds from line of credit		364			—
Payments on line of credit		(364	)		—
Proceeds from stock options exercised		99			66
Borrowings on loans from officer		805			—
Principal payments on capital leases		(149	)		(161	)
Net cash provided by (used by) financing activities		755			(95	)

Net increase in cash and cash equivalents		108			75
Cash and cash equivalents at beginning of period		102			1,006
Cash and cash equivalents at end of period	$	210		$	1,081

SUPPLEMENTAL DISCLOSURE OF NON CASH FINANCING ACTIVITIES:

Preferred stock dividends accrued	$	104		$	104
Purchase of leased equipment under capital lease	$	6		$	225
Conversion of preferred shares to common stock	$	—		$	—

Description of Business

We develop, market and support a family of entity identification, high speed data mining, cybercrime and advanced persistent threat detection products. Our product families include:

●

TraceCop™ for identity discovery and disclosure,

●

Savant™ for network data mining and advanced persistent threat detection.

We market and distribute our products through a direct sales force to:

●

end-users,

●

value-added resellers,

●

system integrators,

●

managed service providers, and

●

distributors.

Our end-user customers include:

●

U.S. federal government entities,

●

local government entities,

●

banks,

●

airlines,

●

credit unions,

●

other financial institutions,

●

hospitals and other healthcare providers, and

●

other customers.

Essentially, our end-users can be defined as any end-users requiring network security solutions for protecting their mission critical data.

We were organized in Texas in September 1983 and reincorporated in Delaware in October 1995. Our principal executive offices are located at 1101 East Arapaho Road, Suite 200, Richardson, Texas 75081, and our telephone number is (972) 234-6400. Our website URL is www.intrusion.com. References to the “Company”, “we”, “us”, “our”, “Intrusion” or “Intrusion Inc.” refer to Intrusion Inc. and its subsidiaries. TraceCop and Savant are trademarks of Intrusion Inc.

2. Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and with the instructions to Form 10-Q and Item 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. The December 31, 2015 balance sheet was derived from audited financial statements, but does not include all the disclosures required by accounting principles generally accepted in the United States. However, we believe that the disclosures are adequate to make the information presented not misleading. In our opinion, all the adjustments (consisting of normal recurring adjustments) considered necessary for fair presentation have been included. The results of operations for the three and nine month periods ended September 30, 2016 are not necessarily indicative of the results that may be achieved for the full fiscal year or for any future period. The unaudited condensed consolidated financial statements included herein should be read in conjunction with the consolidated financial statements and notes thereto included in our annual report on Form 10-K for the year ended December 31, 2015, filed with the U.S. Securities and Exchange Commission (the “SEC”) on March 29, 2016.

The Company calculates the fair value of its assets and liabilities which qualify as financial instruments and includes this additional information in the notes to consolidated financial statements when the fair value is different from the carrying value of these financial instruments. The estimated fair value of accounts receivable, accounts payable and accrued expenses, and dividends payable approximate their carrying amounts due to the relatively short maturity of these instruments. Loans payable to officer are with a related party and as a result do not bear market rates of interest. Management believes based on its current financial position that it could not obtain comparable amounts of third party financing, and as such cannot estimate the fair value of the loans payable to officer. None of these instruments are held for trading purposes.

4. Loan Payable to Officer

On February 4, 2016, the Company entered into an unsecured revolving promissory note to borrow up to $2,200,000 from G. Ward Paxton, the Company’s Chief Executive Officer (the “CEO Note”). Under the terms of the CEO Note, the Company may borrow, repay and reborrow on the loan as needed up to an outstanding principal balance due of $2,200,000 at any given time through March 2018.

On September 30, 2016, the Company renewed the CEO Note on the same terms, with the Company being able to borrow, repay and reborrow on the CEO Note as needed up to an outstanding principal balance due of $2,700,000 at any given time through March 2018.

Amounts borrowed under the CEO Note officer accrue interest at a floating rate per annum equal to Silicon Valley Bank’s (“SVB”) prime rate plus 1% (5% at September 30, 2016). All outstanding borrowings and accrued but unpaid interest is due on March 31, 2018. As of September 30, 2016, the borrowings outstanding totaled $2,335,000 and accrued interest totaled $151,000.

5. Line of Credit

On March 29, 2006, we entered into a Loan and Security Agreement with Silicon Valley Bank (“SVB”) to establish a $1.0 million line of credit (the “2006 Credit Line”). On June 30, 2008, we entered into an Amended and Restated Loan and Security Agreement with SVB to, among other things, replace the 2006 Credit Line with a $2.5 million line of credit (the “2008 Credit Line”). On June 23, 2015, we entered into the Seventh Amendment to the Amended and Restated Loan and Security Agreement (as amended, the “Loan Agreement”) with SVB to replace our expiring line with a $0.625 million line of credit (the “Line of Credit”). Our obligations under the Loan Agreement were secured by substantially all of our assets, including all of our intellectual property. In addition, G. Ward Paxton, the Company’s Chairman, President and Chief Executive Officer, established a Guaranty Agreement with SVB securing all outstanding balances under the Line of Credit. Due to increasing fees associated with the Line of Credit, we chose not to renew the loan agreement on the termination date. We replaced the line with an increased commitment under the CEO Note (Note 4 above) as needed.

6. Accounting for Stock-Based Compensation

During the three month periods ended September 30, 2016 and 2015, the Company did not grant any stock options to employees or directors. The Company recognized $20,000 and $49,000, respectively, of stock-based compensation expense for the three month periods ended September 30, 2016 and 2015. During the nine month periods ended September 30, 2016 and 2015, the Company granted 24,000 and 40,000, respectively, of stock options to employees and directors. The Company recognized $82,000 and $161,000, respectively, of stock-based compensation expense for the nine month periods ended September 30, 2016 and 2015.

During the three month periods ended September 30, 2016 and 2015, no options were exercised under the 2005 Plan. During the nine month periods ended September 30, 2016 and 2015, 136,000 and 150,000 options were exercised under the 2005 Plan, respectively.

Valuation Assumptions

The fair values of employee and director option awards were estimated at the date of grant using a Black-Scholes option-pricing model with the following assumptions:

	For Three Months Ended September 30, 2016		For Three Months Ended September 30, 2015		For Nine Months Ended September 30, 2016			For Nine Months Ended September 30, 2015

Weighted average grant date fair value		-		-	$	0.29		$	2.09
Weighted average assumptions used:
Expected dividend yield		-		-		0.0	%		0.0	%
Risk-free interest rate		-		-		1.38	%		1.37	%
Expected volatility		-		-		96.0	%		176.0	%
Expected life (in years)		-		-		5.0			5.0

Expected volatility is based on historical volatility and in part on implied volatility. The expected term considers the contractual term of the option as well as historical exercise and forfeiture behavior. The risk-free interest rate is based on the rates in effect on the grant date for U.S. Treasury instruments with maturities matching the relevant expected term of the award. Options granted to non-employees are valued using the fair market value on each measurement date of the option.

7. Net Loss Per Share

Basic net loss per share is computed by dividing net loss attributable to common stockholders for the period by the weighted average number of common shares outstanding for the period. Diluted net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted average number of common shares and dilutive common stock equivalents outstanding for the period. Our common stock equivalents include all common stock issuable upon conversion of preferred stock and the exercise of outstanding options and warrants. The aggregate number of common stock equivalents excluded from the diluted loss per share calculation for the three month periods ended September 30, 2016 and 2015 are 3,532,943 and 3,799,949 as they are antidilutive. The aggregate number of common stock equivalents excluded from the diluted loss per share calculation for the nine month periods ended September 30, 2016 and 2015 are 3,545,745 and 3,799,949 as they are antidilutive.

8. Concentrations

Our operations are concentrated in one area—security software/entity identification. Sales to the U.S. Government through direct and indirect channels totaled 78.4% of total revenues for the third quarter of 2016 compared to 55.4% of total revenues for the third quarter of 2015. During the third quarter of 2016, approximately 78.4% of total revenues were attributable to five government customers compared to approximately 50.7% of total revenues attributable to three government customers in the third quarter of 2015. Sales to commercial customers totaled 21.6% of total revenue for the third quarter of 2016 compared to 44.6% of total revenue for the third quarter of 2015. During the third quarter of 2016, approximately 18.9% of total revenue was attributable to one commercial customers compared to approximately 31.6% to two commercial customers in the third quarter of 2015. Our similar product and service offerings are not viewed as individual segments, as our management analyzes the business as a whole and expenses are not allocated to each product offering.

10. Dividends Payable

During the quarter ended September 30, 2016, we accrued $13,000 in dividends payable to the holders of our 5% Preferred Stock, $14,000 in dividends payable to the holders of our Series 2 5% Preferred Stock and $8,000 in dividends payable to the holders of our Series 3 5% Preferred Stock. As of September 30, 2016, we have $267,000 in accrued and unpaid dividends.

Delaware law provides that we may only pay dividends out of our capital surplus or, if no surplus is available, out of our net profits for the fiscal year the dividend is declared and/or the preceding fiscal year. These dividends continue to accrue on all our outstanding shares of preferred stock, regardless of whether we are legally able to pay them. If we are unable to pay dividends on our preferred stock, we will be required to accrue an additional late fee penalty of 18% per annum on the unpaid dividends for the Series 2 Preferred Stock and Series 3 Preferred Stock. Our CEO, CFO and one outside board member who are holders of our Series 2 and Series 3 Preferred Stock have waived any possible late fee penalties. In addition to this late penalty, the holders of our Series 2 Preferred Stock and Series 3 Preferred Stock could elect to present us with written notice of our failure to pay dividends as scheduled, in which case we would have 45 days to cure such a breach. In the event that we failed to cure the breach, the holders of these shares of preferred stock would then have the right to require us to redeem their shares of preferred stock for a cash amount calculated in accordance with their respective certificates of designation. If we were required to redeem all shares of Series 2 Preferred Stock and Series 3 Preferred Stock as of November 1, 2016, the aggregate redemption price we would owe would be $2.2 million.

Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

This Quarterly Report on Form 10-Q, including, without limitation, the section entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Such forward-looking statements are generally accompanied by words such as “estimate,” “expect,” “believe,” “should,” “would,” “could,” “anticipate,” “may” or other words that convey uncertainty of future events or outcomes. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Factors that may cause actual results to differ materially from current expectations, which we describe in more detail elsewhere in this Quarterly Report on Form 10-Q in Part II Item 1A ”Risk Factors”, and in our 2015 Annual Report on Form 10-K in Item 1A “Risk Factors” include, but are not limited to:

If one or more of these or other risks or uncertainties materialize, or if our underlying assumptions prove to be incorrect, actual results may vary significantly from what we projected. These forward-looking statements and other statements made elsewhere in this report are made in reliance on the Private Securities Litigation Reform Act of 1995. Any forward-looking statement you read in this Quarterly Report on Form 10-Q or our Annual Report on Form 10-K reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The section below entitled “Factors That May Affect Future Results of Operations” sets forth and incorporates by reference certain factors that could cause actual future results of the Company to differ materially from these statements.

The following table sets forth, for the periods indicated, certain financial data as a percentage of net revenues. The period-to-period comparison of financial results is not necessarily indicative of future results.

Net Revenues. Net revenues for the quarter and nine months ended September 30, 2016 were $1.6 million and $4.7 million, respectively, compared to $1.6 million and $5.3 million for the same periods in 2015. Product revenues increased $51 thousand for the quarter ended September 30, 2016, and decreased $0.6 million for the nine months ended September 30, 2016 compared to the same periods in 2015. Decreased product revenues were primarily due to a decrease in sales of our Savant product line. TraceCop sales for the quarters ended September 30, 2016 and 2015 were $1.6 million and $1.3 million, respectively. Savant sales were $22 thousand for the quarter ended September 30, 2016 and $0.2 million for the quarter ended September 30, 2015. Customer support and maintenance revenue decreased $8 thousand for the quarter ended September 30, 2016 and $27 thousand for the nine months ended September 30, 2016. This decrease was due to the expiration of all existing maintenance contracts for the current year.

Concentration of Revenues. Revenues from sales to various U.S. government entities totaled $1.3 million, or 78.4% of revenues, for the quarter ended September 30, 2016 compared to $0.9 million, or 55.4% of revenues, for the same period in 2015. Revenues from sales to various U.S. government entities totaled $3.3 million, or 70.0% of revenues, for the nine months ended September 30, 2016 compared to $2.8 million, or 53.0% of revenues, for the same period in 2015. Sales to commercial customers totaled 21.6% of total revenue for the third quarter of 2016 compared to 44.6% of total revenue for the third quarter of 2015. During the third quarter of 2016, approximately 18.9% of total revenue was attributable to one commercial customer compared to approximately 31.6% to two commercial customers in the third quarter of 2015. Although we expect our concentration of revenues to vary among customers in future periods depending upon the timing of certain sales, we anticipate that sales to government customers will continue to account for a significant portion of our revenues in future periods. Sales to the government present risks in addition to those involved in sales to commercial customers which could adversely affect our revenues, including, without limitation, potential disruption to appropriation and spending patterns and the government’s reservation of the right to cancel contracts and purchase orders for its convenience. Although we do not anticipate that any of our revenues with government customers will be renegotiated, a large number of cancelled or renegotiated government orders could have a material adverse effect on our financial results. Currently, we are not aware of any proposed cancellation or renegotiation of any of our existing arrangements with government entities and, historically, government entities have not cancelled or renegotiated orders which had a material adverse effect on our business.

Gross Profit. Gross profit was $1.0 million or 61.8% of net revenues for the quarter ended September 30, 2016, compared to $1.0 million or 63.3% of net revenues for the quarter ended September 30, 2015. Gross profit was $3.0 million or 64.3% of net revenues for the nine months ended September 30, 2016 compared to $3.4 million or 62.8% of net revenues for the nine months ended September 30, 2015. Gross profit on product revenues for the quarter and nine months ended September 30, trended from 63.3% and 62.8%, respectively, in 2015 to 61.8% and 64.3%, respectively, in 2016 mainly due to a change in product mix and slightly higher labor cost associated with TraceCop sales. As noted previously, all current maintenance contracts expired at year-end 2015. Gross profit as a percentage of net revenues is impacted by several factors, including shifts in product mix, changes in channels of distribution, revenue volume, pricing strategies, and fluctuations in revenues of integrated third-party products.

Sales and Marketing. Sales and marketing expenses decreased to $0.4 million for the three months ended September 30, 2016 compared to $0.5 million for the quarter ended September 30, 2015. Sales and marketing expenses decreased to $1.3 million for the nine months ended September 30, 2016 compared to $1.4 million for the same period in 2015. Increased sales and marketing expense was due to increases in sales efforts to commercial customers. Sales and marketing expenses may vary in the future. We believe that these costs will increase through the end of 2016, with increases in revenue.

Research and Development. Research and development expenses decreased to $0.5 million for the quarter ended September 30, 2016 compared to $0.6 million for the same period in 2015. Research and development expenses increased to $1.9 million for the nine months ended September 30, 2016 compared to $1.6 million for the same period in 2015. Research and development costs are expensed in the period incurred. Research and development expenses may vary in the future; however, we believe that these costs will remain relatively constant through the end of 2016, although expenses may be increased relative to increases in revenue.

General and Administrative. General and administrative expenses remained constant at $0.3 million for the quarters ended September 30, 2016 and 2015. General and administrative expenses remained constant at $0.9 million for the nine months ended for September 30, 2016 and 2015. It is expected that general and administrative expenses will remain relatively constant throughout the remainder of 2016, although expenses may be increased relative to increases in revenue.

Interest. Net interest expense increased to $36 thousand for the quarter ended September 30, 2016 compared to $27 thousand for the same period in 2015. Net interest expense increased to $102 thousand for the nine months ended September 30, 2016 compared to $79 thousand for the same period in 2015. The increase in interest expense was primarily due to an increase in the amounts borrowed under the CEO Note. Net interest expense may vary in the future based on our level of borrowing, which will be affected by our cash flow, operating income and capital expenditures.

Our principal source of liquidity at September 30, 2016, was approximately $210 thousand of cash and cash equivalents. At September 30, 2016, we had a working capital deficiency of $1.0 million compared to a $1.8 million deficiency at September 30, 2015.

Net cash used in operations for the nine months ended September 30, 2016, was $606 thousand due to a net loss of $1.2 million and the following use of cash: a $8 thousand decrease in accounts receivable and a $7 thousand decrease in Inventories. This was partially offset by the following sources of cash and non-cash items: $236 thousand increase in deferred revenue, $39 thousand increase in accounts payable and accrued expenses, a $31 thousand decrease in prepaid expenses and other assets, $71 thousand in depreciation expense, $147 thousand in amortization expense of capital leases, $82 thousand in stock-based compensation, and $13 thousand in penalties and waived penalties on dividends. Net cash provided by operations for the nine months ended September 30, 2015, was $282 thousand due to the following sources of cash and non-cash items: $342 thousand increase in deferred revenue, $170 thousand in amortization expense of capital leases, $161 thousand in stock-based compensation, $117 thousand decrease in accounts receivable, $89 thousand decrease in prepaid expenses and other assets, $85 thousand increase in accounts payable and accrued expenses, $61 thousand in depreciation expense, and $3 thousand in penalties and waived penalties on dividends. This was offset by the net loss of $746 thousand. Future fluctuations in inventory balances, accounts receivable and accounts payable will be dependent upon several factors, including, but not limited to, quarterly sales volumes and timing of invoicing, and the accuracy of our forecasts of product demand and component requirements.

Net cash used in investing activities for the nine months ended September 30, 2016, was $41 thousand for net purchases of property and equipment, compared to $112 thousand for net purchases of property and equipment for cash used in investing activities for the nine months ended September 30, 2015.

Net cash provided by financing activities in 2016 was $755 thousand primarily due to proceeds from a loan by an officer of $805 thousand. Other provisions were proceeds from the line-of-credit of $364 thousand and $99 thousand from the exercise of stock options. This was directly offset by the following uses of cash: $364 thousand in payments to the line-of-credit and $149 thousand payment on principal on capital leases. Net cash used by financing activities for the nine months ended September 30, 2015, was $95 thousand primarily due to $161 thousand payment on the principal of capital leases. This was offset by: $66 thousand in proceeds from the exercise of stock options.

At September 30, 2016, the Company did not have any material commitments for capital expenditures.

During the nine months ended September 30, 2016, the Company funded its operations through the use of cash and cash equivalents, borrowing against our line of credit and advances under the CEO Note.

As of September 30, 2016, we had cash and cash equivalents of approximately $210,000, up from approximately $102,000 as of December 31, 2015. We generated a net loss of $280,000 for the quarter ended September 30, 2016 compared to net loss of $432,000 for the quarter ended September 30, 2015. As of September 30, 2016, in addition to cash and cash equivalents of $210,000, we had $635,000 in excess funding under the CEO Note. We are obligated to make payments of accrued dividends on all our outstanding shares of preferred stock that will reduce our available cash resources. Based on projections of growth in revenue and net income in the coming quarters, and the borrowings available previously mentioned, we believe that we will have sufficient cash resources to finance our operations and expected capital expenditures for the next twelve months. We expect to fund our operations through anticipated Company profits and borrowings from the Company’s CEO, and possibly additional investments of private equity and debt, which, if we are able to obtain, will have the effect of diluting our existing common stockholders, perhaps significantly. Any equity or debt financings, if available at all, may be on terms which are not favorable to us and, in the case of equity financings, may result in dilution to our stockholders. If our operations do not generate positive cash flow in the upcoming year, or if we are not able to obtain additional debt or equity financing on terms and conditions acceptable to us, if at all, we may be unable to implement our business plan, fund our liquidity needs or even continue our operations.

We may explore the possible acquisitions of businesses, products and technologies that are complementary to our existing business. We are continuing to identify and prioritize additional security technologies, which we may wish to develop, either internally or through the licensing, or acquisition of products from third parties. While we may engage from time to time in discussions with respect to potential acquisitions, there can be no assurances that any such acquisitions will be made or that we will be able to successfully integrate any acquired business. In order to finance such acquisitions and working capital it may be necessary for us to raise additional funds through public or private financings. Any equity or debt financings, if available at all, may be on terms, which are not favorable to us and, in the case of equity financings, may result in dilution to our stockholders.

We maintain “disclosure controls and procedures,” as defined in Rule 13a-15(e) under the Exchange Act, that are designed to ensure that information required to be disclosed by us in reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating our disclosure controls and procedures, management recognized that disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable assurance of achieving the desired control objectives, and we necessarily are required to apply our judgment in evaluating the cost-benefit relationship of possible disclosure controls and procedures.

Our management, including our principal executive officer and principal financial officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2016, and concluded that the disclosure controls and procedures were effective.

Our management, with the participation of our principal executive officer and principal financial officer, evaluated our “internal control over financial reporting” (as defined in Rule 13a-15(f) under the Exchange Act) as of December 31, 2015, and concluded that there have not been any changes in our internal control over financial reporting that occurred during the quarter ended September 30, 2016, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

We are subject from time to time to various legal proceedings and claims that arise during the ordinary course of our business. We do not believe that the outcome of those "routine" legal matters should have a material adverse effect on our consolidated financial position, operating results or cash flows; however, we can provide no assurances that legal claims that may arise will not have such a material impact in the future.

We are providing the following information regarding changes that have occurred to previously disclosed risk factors from our Annual Report on Form 10-K for the year ended December 31, 2015. In addition to the other information set forth below and elsewhere in this report, you should consider the factors discussed under the heading “Risk Factors” in our Form 10-K for the year ended December 31, 2015 and the previous Quarterly Reports filed on Form 10-Q for the periods ended on March 31, 2016 and June 30, 2016. The risks described in our Quarterly Reports on Form 10-Q are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.

We may not have sufficient cash to operate our business. Additional debt and equity offerings to fund future operations may not be available and, if available, may significantly dilute the value of our currently outstanding common stock.

As of September 30, 2016, we had cash and cash equivalents of approximately $210,000, up from approximately $102,000 as of December 31, 2015. We generated a net loss of $280,000 for the quarter ended September 30, 2016 compared to net loss of $432,000 for the quarter ended September 30, 2015. As of September 30, 2016, in addition to cash and cash equivalents of $210,000, we had $635,000 in excess funding under the CEO Note. We are obligated to make payments of accrued dividends on all our outstanding shares of preferred stock that will reduce our available cash resources. Based on projections of growth in revenue and net income in the coming quarters, and the borrowings and commitments available previously mentioned, we believe that we will have sufficient cash resources to finance our operations and expected capital expenditures for the next twelve months. We expect to fund our operations through anticipated Company profits and borrowings from the Company’s CEO, and possibly additional investments of private equity and debt, which, if we are able to obtain, will have the effect of diluting our existing common stockholders, perhaps significantly. Any equity or debt financings, if available at all, may be on terms which are not favorable to us and, in the case of equity financings, may result in dilution to our stockholders. If our operations do not generate positive cash flow in the upcoming year, or if we are not able to obtain additional debt or equity financing on terms and conditions acceptable to us, if at all, we may be unable to implement our business plan, fund our liquidity needs or even continue our operations.

We had a net loss of $280 thousand for the quarter ended September 30, 2016, and have an accumulated deficit of $61.2 million as of September 30, 2016. To achieve annual profitability, we must generate increased revenue levels.

For the quarter ended September 30, 2016, we generated a net loss of $280 thousand and had an accumulated deficit of approximately $61.2 million as of September 30, 2016, compared to a net loss of $432 thousand for the quarter ended September 30, 2015 and an accumulated deficit of approximately $59.4 million at September 30, 2015. We need to sustain greater revenue levels from the sales of our products if we are to achieve annual profitability. If we are unable to achieve these revenue levels, losses could happen for the near term and possibly longer, and we may not sustain profitability or generate positive cash flow from operations.

A large percentage of our revenues are received from U.S. government entities/resellers, and the loss of any one of these customers could reduce our revenues and materially harm our business and prospects.

A large percentage of our revenues result from sales to U.S. government entities/resellers. If we were to lose one or more of these key relationships, our revenues could decline and our business and prospects may be materially harmed. We expect that even if we are successful in developing relationships with non-governmental customers, our revenues will continue to be concentrated among government entities. For the quarter ended September 30, 2016, sales to U.S. government entities/resellers collectively accounted for 78.4% of our revenues, compared to 55.4% for the comparable period in 2015. The loss of any of these key relationships may send a negative message to other U.S. government entities or non-governmental customers concerning our product offering. We cannot assure you that U.S. government entities will be customers of ours in future periods or that we will be able to diversify our customer portfolio to adequately mitigate the risk of loss of any of these customers.

A large percentage of our revenues are from one product line with a limited number of customers, and the decrease of revenue from sales of this product line could materially harm our business and prospects.

A large percentage of our revenues result from sales of our security product line. Savant revenues were $22 thousand for the quarter ended September 30, 2016 compared to $0.2 million for the same period in 2015. TraceCop revenues were $1.6 million for the quarter ended September 30, 2016, compared to $1.3 million for the same quarter in 2015. There was one individual commercial customer in the third quarter of 2016 attributable for 18.9% of total revenue compared to two customers at 31.6% for the same period in 2015 that exceeded 10% of total revenues for that quarter. If sales of this key product line were to decrease, our revenues could decline and our business and prospects may be materially harmed.

We are highly dependent on sales made through indirect channels, the loss of which would materially adversely affect our operations.

We derived 79.8% of revenue in the third quarter of 2016 through indirect channels of mainly government resellers, compared to 67.4% of our revenues in the quarter ended September 30, 2015. We must continue to expand our sales through these indirect channels in order to increase our revenues. We cannot assure you that our products will gain market acceptance in these indirect sales channels or that sales through these indirect sales channels will increase our revenues. Further, many of our competitors are also trying to sell their products through these indirect sales channels, which could result in lower prices and reduced profit margins for sales of our products.

You will experience substantial dilution upon the conversion or redemption of the shares of preferred stock that we issued in our private placements or in the event we raise additional funds through the issuance of new shares of our common stock or securities convertible or exercisable into shares of common stock.

On November 1, 2016, we had 12,747,836 shares of common stock outstanding. Upon conversion of all outstanding shares of preferred stock, we will have 13,815,279 shares of common stock outstanding, approximately an 8.4% increase in the number of shares of our common stock outstanding.

In addition, management may issue additional shares of common stock or securities exercisable or convertible into shares of common stock in order to finance our continuing operations. Any future issuances of such securities would have additional dilutive effects on the existing holders of our Common Stock.

Further, the occurrence of certain events could entitle holders of our Series 2 Preferred Stock and Series 3 Preferred Stock to require us to redeem their shares for a certain number of shares of our common stock. Assuming (i) we have paid all liquidated damages and other amounts to the holders, (ii) paid all outstanding dividends, (iii) a volume weighted average price of $0.23, which was the ten-day volume weighted average closing price of our common stock on October 28, 2016, and (iv) our 12,747,836 shares of common stock outstanding on October 28, 2016, upon exercise of their redemption right by the holders of the Series 3 Preferred Stock and the Series 2 Preferred Stock, we would be obligated to issue approximately 3,472,000 shares of our common stock. This would represent an increase of approximately 27.2% in the number of shares of our common stock as of October 28, 2016.

The conversion of preferred stock we issued in the private placements may cause the price of our common stock to decline.

The holders of the shares of our 5% Preferred Stock may freely convert their shares of preferred stock and sell the underlying shares of common stock pursuant to Rule 144 of the Securities and Exchange Commission. As of November 1, 2016, 800,000 shares of our 5% Preferred Stock had converted into 1,272,263 shares of common stock and 200,000 shares of our 5% preferred stock, convertible into 318,065 shares of common stock, remain outstanding.

The holders of the shares of Series 2 5% Preferred Stock may freely convert their shares of preferred stock and sell the underlying shares of common stock pursuant to Rule 144 of the Securities and Exchange Commission. As of November 1, 2016, 605,200 shares of Series 2 Preferred Stock had converted into 605,200 shares of common stock and 460,000 shares of Series 2 5% preferred stock remain outstanding.

The holders of the shares of Series 3 5% Preferred Stock may freely convert their shares of Series 3 Preferred Stock and sell the underlying shares of common stock pursuant to Rule 144 of the Securities and Exchange Commission. As of November 1, 2016, 275,230 shares of Series 3 Preferred Stock had converted into 275,230 shares of common stock and 289,377 shares of Series 3 5% preferred stock remain outstanding.

For the four weeks ended on October 28, 2016, the average daily trading volume of our common stock on the OTCQB was 4,355 shares. Consequently, if holders of preferred stock elect to convert their remaining shares and sell a material amount of their underlying shares of common stock on the open market, the increase in selling activity could cause a decline in the market price of our common stock. Furthermore, these sales, or the potential for these sales, could encourage short sales, causing additional downward pressure on the market price of our common stock.

You will experience substantial dilution upon the exercise of stock options currently outstanding.

On November 1, 2016, we had 12,747,836 shares of common stock outstanding. Upon the exercising of current options exercisable at or below the exercise price of $1.10, we will have approximately 14,905,000 shares of common stock outstanding, an 18.0% increase in the number of shares of our common stock outstanding.

Our management and larger stockholders exercise significant control over our company and have the ability to approve or take actions that may be adverse to your interests.

As of November 1, 2016, our executive officers, directors and preferred stockholders beneficially own approximately 29% of our voting power. In addition, other related parties control approximately 30% of voting power. As a result, these stockholders will be able to exercise significant control over all matters requiring stockholder approval, including the election of directors and approval of significant corporate transactions, which could delay or prevent someone from acquiring or merging with us. These stockholders may use their influence to approve or take actions that may be adverse to the interests of holders of our Common Stock. Further, we contemplate the possible issuance of shares of our Common Stock or of securities exercisable or convertible into shares of our Common Stock in the future to our Chief Executive Officer and Chief Financial Officer. Any such issuance will increase the percentage of stock our Chief Executive Officer, Chief Financial Officer and our management group beneficially holds.

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2016

OR

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number 0-20191

Delaware		75-1911917
(State or other jurisdiction of		(I.R.S. Employer
incorporation or organization)		Identification No.)

	Large accelerated filer ☐	Accelerated filer ☐

	Non-accelerated filer ☐	Smaller reporting company ☒
	(Do not check if a smaller reporting company)

PART I – FINANCIAL INFORMATION	3

Item 1. Financial Statements	3

Unaudited Condensed Consolidated Balance Sheets as of September 30, 2016 and December 31, 2015	3

Unaudited Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2016 and 2015	4

Unaudited Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2016 and 2015	5

Notes to Unaudited Condensed Consolidated Financial Statements	6

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	9

Item 4. Controls and Procedures	12

PART II – OTHER INFORMATION	13

Item 1. Legal Proceedings	13

Item 1A. Risk Factors	13

Item 6. Exhibits	15

Signature Page	16

	Three Months Ended						Nine Months Ended
	September 30, 2016			September 30, 2015			September 30, 2016			September 30, 2015
Net product revenue		100.0	%		99.5	%		100.0	%		99.5	%
Net customer support and maintenance revenue		0.0			0.5			0.0			0.5
Total revenue		100.0			100.0			100.0			100.0
Cost of product revenue		38.2			36.5			35.7			37.0
Cost of customer support and maintenance revenue		0.0			0.2			0.0			0.2
Total cost of revenue		38.2			36.7			35.7			37.2
Gross profit		61.8			63.3			64.3			62.8
Operating expenses:
Sales and marketing		26.8			31.6			27.2			26.8
Research and development		31.9			38.1			40.7			30.8
General and administrative		18.4			19.7			20.0			17.7

Operating income (loss)		(15.3	)		(26.1	)		(23.6	)		(12.5	)

Interest expense		(2.3	)		(1.7	)		(2.2	)		(1.5	)
Other income		—			—			—			—

Income (loss) before income tax provision		(17.6	)		(27.8	)		(25.8	)		(14.0	)

Income tax provision		—			—			—			—

Net income (loss)		(17.6	)%		(27.8	)%		(25.8	)%		(14.0	)%
Preferred stock dividends accrued		(2.2	)		(2.3	)		(2.2	)		(1.9	)

Net income (loss) attributable to common stockholders		(19.8	)%		(30.1	)%		(28.0	)%		(15.9	)%

	September 30, 2016		December 31, 2015

Inventories consist of:
Finished products		52		45
Net inventory	$	52		45

31.1		Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) of the Exchange Act.
31.2		Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) of the Exchange Act.
32.1		Certification Pursuant to Rule 13a-14(b) of the Exchange Act and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS		XBRL Instance Document
101.SCH		XBRL Taxonomy Extension Schema Document
101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document
101.LAB		XBRL Taxonomy Extension Label Linkbase Document
101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document
101.DEF		XBRL Taxonomy Extension Definition Linkbase Document

	INTRUSION INC.

Date: November 14, 2016	/s/ G. Ward Paxton
	G. Ward Paxton
	Chairman, President & Chief Executive Officer
	(Principal Executive Officer)


Date: November 14, 2016	/s/ Michael L. Paxton
	Michael L. Paxton
	Vice President, Chief Financial Officer,
	Treasurer & Secretary
	(Principal Financial & Accounting Officer)